User profiles for Claire Palles

Claire Palles

University of Birmingham
Verified email at bham.ac.uk
Cited by 9850

[HTML][HTML] COVID-19 mortality in patients with cancer on chemotherapy or other anticancer treatments: a prospective cohort study

…, AFC Okines, AC Olsson-Brown, C Palles… - The Lancet, 2020 - thelancet.com
Background Individuals with cancer, particularly those who are receiving systemic anticancer
treatments, have been postulated to be at increased risk of mortality from COVID-19. This …

[HTML][HTML] COVID-19 prevalence and mortality in patients with cancer and the effect of primary tumour subtype and patient demographics: a prospective cohort study

…, T Newsom-Davis, AC Olsson-Brown, C Palles… - The Lancet …, 2020 - thelancet.com
Background Patients with cancer are purported to have poor COVID-19 outcomes. However,
cancer is a heterogeneous group of diseases, encompassing a spectrum of tumour …

Germline mutations affecting the proofreading domains of POLE and POLD1 predispose to colorectal adenomas and carcinomas

C Palles, JB Cazier, KM Howarth, E Domingo… - Nature …, 2013 - nature.com
Many individuals with multiple or large colorectal adenomas or early-onset colorectal cancer
(CRC) have no detectable germline mutations in the known cancer predisposition genes. …

DNA polymerase ɛ and δ exonuclease domain mutations in endometrial cancer

DN Church, SEW Briggs, C Palles… - Human molecular …, 2013 - academic.oup.com
Accurate duplication of DNA prior to cell division is essential to suppress mutagenesis and
tumour development. The high fidelity of eukaryotic DNA replication is due to a combination …

Clinical relevance of DPYD variants c. 1679T> G, c. 1236G> A/HapB3, and c. 1601G> A as predictors of severe fluoropyrimidine-associated toxicity: a systematic …

…, P Kleiblova, M Schwab, UM Zanger, C Palles… - The Lancet …, 2015 - thelancet.com
Background The best-known cause of intolerance to fluoropyrimidines is dihydropyrimidine
dehydrogenase (DPD) deficiency, which can result from deleterious polymorphisms in the …

Deciphering colorectal cancer genetics through multi-omic analysis of 100,204 cases and 154,587 controls of European and east Asian ancestries

…, V Díez-Obrero, L Hsu, J Fernandez-Tajes, C Palles… - Nature …, 2023 - nature.com
Colorectal cancer (CRC) is a leading cause of mortality worldwide. We conducted a genome-wide
association study meta-analysis of 100,204 CRC cases and 154,587 controls of …

A panoply of errors: polymerase proofreading domain mutations in cancer

E Rayner, IC Van Gool, C Palles, SE Kearsey… - Nature Reviews …, 2016 - nature.com
Although it has long been recognized that the exonucleolytic proofreading activity intrinsic
to the replicative DNA polymerases Pol δ and Pol ε is essential for faithful replication of DNA, …

[HTML][HTML] Increased somatic mutation burdens in normal human cells due to defective DNA polymerases

PS Robinson, THH Coorens, C Palles, E Mitchell… - Nature …, 2021 - nature.com
Mutation accumulation in somatic cells contributes to cancer development and is proposed
as a cause of aging. DNA polymerases Pol ε and Pol δ replicate DNA during cell division. …

Common variation near CDKN1A, POLD3 and SHROOM2 influences colorectal cancer risk

…, SE Dobbins, SM Farrington, AM Jones, C Palles… - Nature …, 2012 - nature.com
We performed a meta-analysis of five genome-wide association studies to identify common
variants influencing colorectal cancer (CRC) risk comprising 8,682 cases and 9,649 controls. …

POLE Proofreading Mutations Elicit an Antitumor Immune Response in Endometrial Cancer

…, E Stelloo, E Marchi, M de Bruyn, C Palles… - Clinical Cancer …, 2015 - AACR
Purpose: Recent studies have shown that 7% to 12% of endometrial cancers are ultramutated
due to somatic mutation in the proofreading exonuclease domain of the DNA replicase …